Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Medtronic
Baxter
Dow
Colorcon

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Brigham and Women's Hospital Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2008)

See Plans and Pricing

« Back to Dashboard

Brigham and Women's Hospital Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2008)

Docket   Start Trial Date Filed 2008-07-25
Court District Court, D. Delaware Date Terminated 2011-02-16
Cause 35:271 Patent Infringement Assigned To Judge Harvey Bartle, III
Jury Demand None Referred To
Parties AMGEN INC.; BARR LABORATORIES INC.; BRIGHAM AND WOMEN'S HOSPITAL INC.; NPS PHARMACEUTICALS INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA INC.
Patents 6,001,884; 6,011,068; 6,211,244; 6,313,146
Attorneys Jack B. Blumenfeld; Mary W. Bourke; Maryellen Noreika; Richard D. Kirk; Richard K. Herrmann
Link to Docket External link to docket
Small Molecule Drugs cited in Brigham and Women's Hospital Inc. v. Teva Pharmaceuticals USA Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Brigham and Women's Hospital Inc. v. Teva Pharmaceuticals USA Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Brigham and Women's Hospital Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-07-25 1 Complaint 146 patent”), United States Patent No. 6,011,068 (“the ‘068 patent”) and United States Patent No. 6,…specifically here 76. United States Patent No. 6,011,068 (“the ‘068 patent”), entitled “Calcium Receptor-Active…Page 14 of 30 91. United States Patent No. 6,011,068 (“the ‘068 patent”), entitled “Calcium Receptor-Active…infringement of United States Patent No. 6,211,244 (“the ‘244 patent”), United States Patent No. 6,313,146 (“the…the ‘003 patent”) (collectively referred to as “the Patents”) arising under United States patent laws, Title External link to document
2008-08-18 10 Answer to Complaint of U.S. Patents Nos. 6,211,244 (“the ‘244 patent”); 6,313,146 (“the ‘146 patent”); 6,011,068 (“the ‘068…‘068 patent”); and 6,031,003 (“the ‘003 patent”). The claims of these patents speak for themselves. …18. The ‘244 patent speaks for itself, and Teva admits that a copy of the ‘244 patent is attached to…47. The ‘146 patent speaks for itself, and Teva admits that a copy of the ‘146 patent is attached to…76. The ‘068 patent speaks for itself, and Teva admits that a copy of the ‘068 patent is attached to External link to document
2008-08-18 11 Answer to Complaint , United States Patent No. 6,011,068 (“the ‘068 patent”) and United States Patent No. 6,031,003 (“the …States Patent and Trademark Office issued United States Patent No. 6,011,068 (“the ‘068 patent”), listing… 76. United States Patent No. 6,011,068 (“the ‘068 patent”), entitled “Calcium Receptor-Active…. 91. United States Patent No. 6,011,068 (“the ‘068 patent”), entitled “Calcium Receptor-Active…States Patent No. 6,211,244 (“the ‘244 patent”), United States Patent No. 6,313,146 (“the ‘146 patent”), External link to document
2010-03-31 184 quot;), 6,011,068 (the "'068 patent"), and 6,031,003 (the "'003 patent"). …pharmaceutical patents No. 6,211,244 (the "'244 patent"), 6,313,146 (the "'146 patent"… the patent terms of the '146, '068, and '003 patents. To be patentable, an invention…assignees of one or more of the patents in suit. These patents pertain to the pharmaceutical compound…#39;068, and '003 patents when they failed to cite to the respective patent examiners the then pending External link to document
2010-09-21 214 quot;), 6,011,068 (the "'068 patent"), and 6,031,003 (the "'003 patent"). …pharmaceutical patents No. 6,211,244 (the "'244 patent"), 6,313,146 (the "'146 patent"…of the '244 patent is patentably indistinct from claim 26 of the '068 patent, when defendants…#39;244 patent contains 44 claims, the '146 patent contains 55 claims, the '068 patent states…;541 patent was material to the '244 patent prosecution only because of the '541 patent' External link to document
2010-10-29 232 COVENANT NOT TO SUE FOR INFRINGEMENT OF U.S. PATENT NO. 6,313,146 - by Amgen Inc., Barr Laboratories Inc.,…2008 16 February 2011 1:08-cv-00464-HB Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Johnson and Johnson
Harvard Business School
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.